Richmond Pharmacology welcomes you to attend the ACCP 40th Annual Meeting, taking place 11th to 13th Sept, 2011

Posted:
9
September 2011

Richmond Pharmacology welcomes you to attend the ACCP 40th Annual Meeting, taking place 11th to 13th Sept, 2011 at the Crowne Plaza Chicago O'Hare Hotel. This years meeting promises to be an exciting event that will hosting a series of excellent workshops and symposia on current, relevant topics related to improving the optimal development and use of therapeutics, with a specific focus on clinical pharmacology.Richmond Pharmacologys CEO and co-founder Dr Jorg Taubel is due to present on Monday 12th September from 18h00 to 20h00, covering the following topics of discussion:

  • Alternative Methods for The Confirmation Of Assay Sensitivity In Thorough QT Studies
  • The Use of Non-invasive Blood Pressure Recording By Photoplethysmography In Early Phase Clinical Trial Studies

Furthermore, Richmond Pharmacology will be exhibiting at the meeting, if you plan to attend we welcome you to come see us at booth number 3 to learn more about our service offering and how our specialist expertise can enhance your next clinical study. If you would like to arrange a face to face meeting with Dr Taubel, please contact a member of our business development team to arrange a time at your convenience.

Latest news

Upcoming Event

EUFEMED, 3rd Annual Conference, 28-30 April 2021

28-30 April 2021
Dr Jorg Taubel will co-chair a session on day one, which explores how technology has reduced the risks of pandemic effects on Phase I and II trial performance.
View event

Novel rate-controlled fentanyl patch shows promise in phase I clinical trial

April 1, 2021
Our expertise in ethnic differences and access to over 12,000 first generation Japanese volunteers accelerated our ability to provide robust clinical trial data to support future applications of new chronic pain medicines to the Japanese drug market.
Read more

A new era for UK-Japanese scientific relations

March 23, 2021
Dr Taubel uses his experience of conducting more than 60 Japanese bridging studies to explain why the deal is of strategic importance to the UK and highlights the scientific requirements for conducting successful Japanese trials abroad
Read more

Richmond Pharmacology’s local MP Neil Coyle calls on the Government to evaluate the potential of using Clinical Research Organisations.

February 3, 2021
Richmond Pharmacology has offered its services to the Government and the NHS as an additional vaccine site in London
Read more